Aseptic Technologies vials are well suited for Cell Therapy applications: they provide the quality standards for creating a pharmaceutical product, and the closed filling process provides greater sterility assurance compared to open vials. The company has supported applications with a range of lot sizes - enabling Cell Therapies across the scalability spectrum

Jon Rowley

Former Innovation Director of Lonza's Cell Therapy Business, current CEO of RoosterBio, Inc